ES2075437T3 - Nuevo derivado del acido cafeico, el oraposido, composicion cosmetica o farmaceutica, particularmente dermatologica que lo contiene. - Google Patents
Nuevo derivado del acido cafeico, el oraposido, composicion cosmetica o farmaceutica, particularmente dermatologica que lo contiene.Info
- Publication number
- ES2075437T3 ES2075437T3 ES91907075T ES91907075T ES2075437T3 ES 2075437 T3 ES2075437 T3 ES 2075437T3 ES 91907075 T ES91907075 T ES 91907075T ES 91907075 T ES91907075 T ES 91907075T ES 2075437 T3 ES2075437 T3 ES 2075437T3
- Authority
- ES
- Spain
- Prior art keywords
- new derivative
- pct
- oraposide
- cosmetic
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/18—Acyclic radicals, substituted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/004—Aftersun preparations
Abstract
LA INVENCION CONCIERNE A UN NUEVO DERIVADO DEL ACIDO CAFEICO. ESTE NUEVO DERIVADO PRESENTA LA FORMULA (I) EN LA CUAL UNO O VARIOS R REPRESENTAN INDEPENDIENTEMENTE UN ATOMO DE HIDROGENO, UN GRUPO ALQUILO EN C1-C5, EN PARTICULAR METILO, UN GRUPO ACILO, EN PARTICULAR EN C1-C6, SOBRE TODO ACETILO. ESTE NUEVO DERIVADO DENOMINADO ORAPOXIDO ES PARTICULARMENTE UTIL PARA LA PREPARACION DE COMPOSICIONES COSMETICAS O FARMACEUTICAS, EN PARTICULAR DERMATOLOGICAS, GRACIAS SOBRE TODO A UNA ACTIVIDAD ANTIRADICALES LIBRES, ANTIINFLAMATORIAS Y ANTIENVEJECIMIENTO ACTINICO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/FR1991/000229 WO1992016544A1 (fr) | 1991-03-21 | 1991-03-21 | Nouveau derive de l'acide cafeique, l'oraposide, composition cosmetique ou pharmaceutique, notamment dermatologique le contenant |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2075437T3 true ES2075437T3 (es) | 1995-10-01 |
Family
ID=34834297
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES91907075T Expired - Lifetime ES2075437T3 (es) | 1991-03-21 | 1991-03-21 | Nuevo derivado del acido cafeico, el oraposido, composicion cosmetica o farmaceutica, particularmente dermatologica que lo contiene. |
Country Status (10)
Country | Link |
---|---|
US (1) | US5719129A (es) |
EP (1) | EP0576420B1 (es) |
JP (1) | JP3147900B2 (es) |
KR (1) | KR100194830B1 (es) |
AT (1) | ATE123287T1 (es) |
AU (1) | AU670742B2 (es) |
CA (1) | CA2102689A1 (es) |
DE (1) | DE69110136T2 (es) |
ES (1) | ES2075437T3 (es) |
WO (1) | WO1992016544A1 (es) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4444238A1 (de) * | 1994-12-13 | 1996-06-20 | Beiersdorf Ag | Kosmetische oder dermatologische Wirkstoffkombinationen aus Zimtsäurederivaten und Flavonglycosiden |
DE19615575A1 (de) * | 1996-04-19 | 1997-10-23 | Beiersdorf Ag | Verwendung von Glucosiden und Ferulasäure als antiirritativer Wirkstoff in kosmetischen und topischen dermatologischen Zubereitungen |
WO1998042324A2 (en) * | 1997-03-21 | 1998-10-01 | The Regents Of The University Of California | Methods for modulating neurotrophic factor-associated activity using aldose reductase inhibitors |
US6696407B1 (en) | 1997-03-21 | 2004-02-24 | The Regents Of The University Of California | Huntington's disease treatment comprising administering aldose reductase inhibitors to increase striatal CNTF |
US6679584B2 (en) * | 1997-07-15 | 2004-01-20 | Silverbrook Research Pty Ltd. | High volume pagewidth printing |
US8466109B2 (en) * | 1998-10-05 | 2013-06-18 | Laboratoires Expanscience | Cosmetic method for preventing and/or treating skin stretchmarks, and use in dermatology |
JP2002528476A (ja) * | 1998-11-02 | 2002-09-03 | チバ スペシャルティ ケミカルズ ホールディング インコーポレーテッド | ボディケア及び家庭用製品の安定化 |
FR2787996B1 (fr) * | 1998-12-30 | 2002-05-10 | Dior Christian Parfums | Composition cosmetique ou dermatologique contenant un actif stimulant la synthese de la proteine hsp 32 dans la peau et methode de traitement cosmetique |
US20040228816A1 (en) * | 1998-12-30 | 2004-11-18 | Carine Nizard | Cosmetic or dermatological composition containing an active agent which stimulates synthesis of the protein HSP 32 in the skin |
IT1317732B1 (it) | 2000-01-20 | 2003-07-15 | Giuliani Spa | Composti ad attivita' antiossidante, composizioni utili qualiintegratori alimentari che li contengono e procedimento per |
AU2000258901A1 (en) | 2000-04-06 | 2001-10-23 | Nicholas V. Perricone | Treatment of skin damage using olive oil polyphenols |
EP1166765A3 (de) * | 2000-06-20 | 2002-05-02 | Laboratoires Serobiologiques | Verfahren zum Schutz der menschlichen Haut |
US7713569B2 (en) | 2000-09-01 | 2010-05-11 | Creagri, Inc. | Hydroxytyrosol-rich composition from olive vegetation water and method of use thereof |
EP1315691B2 (en) * | 2000-09-01 | 2017-09-13 | Creagri, Inc. | Method of obtaining a hydroxytyrosol-rich composition from vegetation water |
EP1260212A1 (de) * | 2001-05-21 | 2002-11-27 | Cognis France S.A. | Kosmetische Mittel |
JP2002363075A (ja) | 2001-06-05 | 2002-12-18 | Kao Corp | 高血圧症予防・治療剤 |
US8216599B2 (en) * | 2002-02-13 | 2012-07-10 | Creagri, Inc. | Method for treatment of inflammation |
DE10215055A1 (de) * | 2002-04-03 | 2003-10-30 | Univ Schiller Jena | Verwendung von Kaffeesäureestern zur Herstellung von kosmetischen nutrazeutischen sowie pharmazeutischen Präparaten und Arzneimitteln |
CN100467033C (zh) * | 2003-03-31 | 2009-03-11 | 科学与工业研究会 | 植物性保肝剂及其制造方法 |
US6989162B2 (en) * | 2003-03-31 | 2006-01-24 | Council Of Scientific & Industrial Research | Hepatoprotective agent of plant origin and a process thereof |
US20060020029A1 (en) * | 2004-07-02 | 2006-01-26 | Shimasaki Craig D | Pharmaceutical compositions from ethnobotanicals |
US20080300198A1 (en) * | 2004-08-09 | 2008-12-04 | Kathleen Matt | Olive Compositions and Methods for Treating Inflammatory Conditions |
US9789149B2 (en) * | 2005-07-19 | 2017-10-17 | Creagri, Inc. | Vegetation water composition for treatment of inflammatory skin conditions |
FR2892923B1 (fr) * | 2005-11-08 | 2009-01-16 | Engelhard Lyon Sa | Utilisatiion des derives de l'acide para-coumarique ou para- hydroxycinnamique dans des compositions cosmetiques ou dermatologiques. |
US20080167277A1 (en) * | 2006-12-29 | 2008-07-10 | Charles Conrad | Methods of treating skin disorders with caffeic acid analogs |
JPWO2008093678A1 (ja) * | 2007-01-29 | 2010-05-20 | オリザ油化株式会社 | ヒアルロニダーゼ阻害剤 |
JP2009263279A (ja) * | 2008-04-25 | 2009-11-12 | Oriza Yuka Kk | エラスターゼ阻害剤 |
US8450337B2 (en) * | 2008-09-30 | 2013-05-28 | Moleculin, Llc | Methods of treating skin disorders with caffeic acid analogs |
WO2012143017A1 (en) | 2011-04-17 | 2012-10-26 | El-Sawy Mohamed Fakhr El-Din | The use of orobancheace extract for the treatment of hepatitis c virus and nonalcoholic fatty liver disease |
GB201705403D0 (en) * | 2017-04-04 | 2017-05-17 | Givaudan Sa | Improvements in or relating to organic compounds |
CN109776633B (zh) * | 2019-03-18 | 2020-08-04 | 暨南大学 | 一种苯丙素类化合物及其制备方法与应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2302745A1 (fr) * | 1975-03-07 | 1976-10-01 | Screen | Esters heterosidiques d'acide cafeique, leurs procedes de preparation e |
FR2314725A1 (fr) * | 1975-03-07 | 1977-01-14 | Screen | Procede pour la preparation d'heterosides de dihydroxyphenylalcanol et medicaments contenant de tels heterosides |
FR2652086B1 (fr) * | 1989-09-20 | 1993-05-21 | Andary Claude | Compose nouveau d'origine vegetale, derive de l'acide cafeique, l'oraposide; composition a usage therapeutique et composition dermato-cosmetique le contenant. |
-
1991
- 1991-03-21 AU AU75850/91A patent/AU670742B2/en not_active Ceased
- 1991-03-21 JP JP50647591A patent/JP3147900B2/ja not_active Expired - Fee Related
- 1991-03-21 US US08/119,172 patent/US5719129A/en not_active Expired - Lifetime
- 1991-03-21 AT AT91907075T patent/ATE123287T1/de active
- 1991-03-21 ES ES91907075T patent/ES2075437T3/es not_active Expired - Lifetime
- 1991-03-21 CA CA002102689A patent/CA2102689A1/fr not_active Abandoned
- 1991-03-21 DE DE69110136T patent/DE69110136T2/de not_active Expired - Fee Related
- 1991-03-21 KR KR1019930702831A patent/KR100194830B1/ko not_active IP Right Cessation
- 1991-03-21 EP EP91907075A patent/EP0576420B1/fr not_active Expired - Lifetime
- 1991-03-21 WO PCT/FR1991/000229 patent/WO1992016544A1/fr active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
CA2102689A1 (fr) | 1992-09-22 |
AU7585091A (en) | 1992-10-21 |
EP0576420A1 (fr) | 1994-01-05 |
KR100194830B1 (ko) | 1999-06-15 |
JPH06508601A (ja) | 1994-09-29 |
ATE123287T1 (de) | 1995-06-15 |
WO1992016544A1 (fr) | 1992-10-01 |
US5719129A (en) | 1998-02-17 |
DE69110136D1 (de) | 1995-07-06 |
EP0576420B1 (fr) | 1995-05-31 |
AU670742B2 (en) | 1996-08-01 |
JP3147900B2 (ja) | 2001-03-19 |
DE69110136T2 (de) | 1996-01-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2075437T3 (es) | Nuevo derivado del acido cafeico, el oraposido, composicion cosmetica o farmaceutica, particularmente dermatologica que lo contiene. | |
ES2069388T3 (es) | Derivados s-triazinicos que llevan sustituyentes benzalmalonatos, su procedimiento de preparacion, composiciones cosmeticas filtrantes que los contienen, y su empleo para proteger la piel y los cabellos de las radiaciones ultravioleta. | |
ES2113416T3 (es) | Derivados s-triazinicos que llevan sustituyentes benciliden-alcanfor, su procedimiento de preparacion, composiciones cosmeticas filtrantes que los contienen y su utilizacion para proteger la piel y los cabellos de la radiacion ultravioleta. | |
MX9400206A (es) | Derivados de vinil-azaindol, proceso para su preparacion y composiciones farmaceuticas que los contienen. | |
DE69522947T2 (de) | Phenylxanthin-derivate | |
KR890000077A (ko) | 화장용 또는 국소제제로 사용하기 위한 방취 및 항균조성물 | |
TW274547B (es) | ||
ES2114645T3 (es) | Utilizacion de un fosfato de alfa-tocoferol, o de uno de sus derivados para la preparacion de una composicion cosmetica, dermatologica o farmaceutica, de actividad anti-radicalar; composicion asi obtenida. | |
DK0553241T3 (da) | Anvendelse af sammensætninger på basis af fedtalkoholer til fremstilling af emulsioner, fremgangsmåd e til fremstilling af emulsioner og således fremstillede emulsioner | |
AR037329A1 (es) | Compuestos pirazolo pirimidinona, procedimientos para la preparacion de los mismos, composiciones farmaceuticas de los mismos y usos de los mismos en la preparacion de medicamentos | |
AR029383A1 (es) | Moleculas pequenas, los intermediarios para su sintesis, las composiciones farmaceuticas que las contienen y su uso para preparar un medicamento destinado al tratamiento o la profilaxis de enfermedades inflamatorias o mediadas por celulas inmunes | |
MX9202166A (es) | Derivados de amidino fenil alanina, procedimiento para su preparacion su empleo y agentes que los con tienen en calidad de anticoagulantes. | |
ES2098004T3 (es) | Peptidos derivados de trifluoro-metil-cetonas con una actividad inhibidora de la elastasa leucocitaria humana (hle), su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
HUP0003424A2 (hu) | Dermatológiai készítmények | |
AR005827A1 (es) | Compuesto derivado de nucleosidos aciclicos, composicion farmaceutica que lo comprende, uso del mismo en la preparacion de un medicamento y su metodo de preparacion | |
ES2084371T3 (es) | Composiciones cosmeticas que contienen un extracto de eclipta alba. | |
SE8000131L (sv) | Kompositioner for anvendning som kosmetiska medel samt ett forfarande for framstellning av de aktiva komponenterna deri | |
AR002017A1 (es) | Derivados de fenil-4-tiazoles substituidos, procedimiento para su preparacion, composiciones farmaceuticas que los contienen y derivados defenil-4-tiazoles substituidos empleados en dicho procedimiento. | |
JPS6429352A (en) | Novel polycyclic aromatic compound, medicine and cosmetic composition | |
DE69413831D1 (de) | Phenoxyphenylcyclopentenyl-hydroxyharnstoffe | |
GB1153994A (en) | Hydroxyphenyl Anthranilic Acid Derivatives Capable of Absorbing 'Ultra-Violet Light and Compositions containing them | |
ES2095501T3 (es) | Nuevos agentes yodados no ionicos de contraste a los rayos x, metodo para su preparacion y composiciones galenicas que los contienen. | |
DK0539465T3 (da) | Anvendelse af 20(R)-22-oxa-D-vitamin-analoger til fremstilling af et farmaceutisk præparat til behandling og/eller forebyggelse af hudaldring | |
AR008107A1 (es) | Un compuesto de la familia de las aril 2,4-dioxo oxazolidinas, su utilizacion, procedimiento para su preparacion, composiciones cosmeticas yfarmaceuticas que lo contienen y un procedimiento de tratamiento cosmetico | |
SE8100946L (sv) | Nya indanderivat, sett att framstella dem, anvendning derav som farmaceutika och farmaceutiska kompositioner som innehaller dess derivat |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 576420 Country of ref document: ES |